Table 3 Variables excluded as significant predictors of therapeutic alliance determined through stepwise regression
Stepwise regression variable | Beta In | t | p |
|---|---|---|---|
Early Treatment Alliance Model | |||
Previous specialist ED intervention | .362 | 1.73 | .12 |
Baseline ANSOQC Total | .142 | .57 | .58 |
Duration of illness | -.052 | -.22 | .83 |
Age | -.026 | -.11 | .92 |
Baseline BMI | -.173 | -.72 | .49 |
Baseline rating of treatment suitability | .278 | 1.03 | .33 |
Baseline EDE Global score | -.039 | -.17 | .87 |
Mid Treatment Alliance Model | |||
Previous specialist ED intervention | .119 | .49 | .64 |
Baseline ANSOQC Total | .366 | 1.64 | .15 |
Duration of illness | -.353 | -1.70 | .14 |
Age | -.435 | -1.81 | .12 |
Baseline BMI | -.403 | -1.63 | .16 |
Baseline rating of treatment suitability | -.225 | -.74 | .49 |
Baseline EDE Global score | -.281 | -1.26 | .25 |
Early Treatment HRQ Total | .087 | .27 | .80 |
Late Treatment Alliance Model | |||
Previous specialist ED intervention | -.091 | -.34 | .74 |
Baseline ANSOQC Total | -.176 | -.61 | .56 |
Duration of illness | -.229 | -.86 | .41 |
Age | -.021 | -.07 | .95 |
Baseline BMI | .300 | .98 | .36 |
Baseline rating of treatment suitability | -.147 | -.44 | .67 |
Baseline EDE Global score | -.049 | -.18 | .86 |
Early Treatment HRQ Total | .205 | .66 | .53 |